Retina/Vitreous

Top Story

BLOG: What’s ahead in 2019

December 14, 2018
In the JournalsPerspective

Increase in choroidal thickness seen after CPAP therapy

December 14, 2018
Patients with obstructive sleep apnea syndrome who underwent continuous positive airway pressure therapy experienced an increase in choroidal thickness after 12 months…

OD-OS releases software for iridotomy treatment with Navilas 577s laser

December 14, 2018
OD-OS has released new software for the Navilas 577s retinal laser system. The version 3.5 software includes an intuitive anterior segment treatment mode for laser…

New technology detects firing of nerve cells

December 13, 2018
Technology that can detect when nerve cells fire, which can be used to observe nerve activity in the eye as well as other light-accessible parts of the body, has been…
More Headlines »
Case Report

Mushroom-Shaped Secondary Vasoproliferative Tumor

Ophthalmic Surgery, Lasers and Imaging Retina, Volume 5
Online Only, September 1, 2012
The authors report a clinical and echographic correlation of a retinal vasoproliferative tumor that assumed a mushroom…
More »
CME

Advancing Science on Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because…
More »
Video From OSN Europe
Meeting News

VIDEO: Large cohort shows safety of Ozurdex for DME

October 8, 2018
More »
Blog

BLOG: What’s ahead in 2019

December 14, 2018
If you want to know the future, look no further than the FDA’s coming Prescription Drug User Fee Act announcements calendar. While not all…

In the JournalsPerspective

Increase in choroidal thickness seen after CPAP therapy

December 14, 2018
Patients with obstructive sleep apnea syndrome who underwent continuous positive airway pressure therapy experienced an increase in choroidal…

OD-OS releases software for iridotomy treatment with Navilas 577s laser

December 14, 2018
OD-OS has released new software for the Navilas 577s retinal laser system. The version 3.5 software includes an intuitive anterior segment treatment…

New technology detects firing of nerve cells

December 13, 2018
Technology that can detect when nerve cells fire, which can be used to observe nerve activity in the eye as well as other light-accessible parts of…

Gene therapy fails to show clinical activity in X-linked retinoschisis

December 13, 2018
An investigational AAV-based gene therapy from Applied Genetic Technologies Corporation for X-linked retinoschisis due to mutations in the RS1 gene…

Europe’s Luxturna approval tops November retina news

December 12, 2018
The European Commission’s approval of Luxturna for inherited retinal disease was the most-read retina-related article on Healio.com/OSN in…

Quality of life improvements sustained in trial of GenSight’s LHON treatment

December 12, 2018
GS010 for Leber hereditary optic neuropathy demonstrated quality of life improvements in a phase 3 clinical trial, GenSight Biologics announced in a…

ProQR awarded innovation credit for development of LCA10 treatment

December 10, 2018
The Dutch government has awarded ProQR a 4.7 million euro innovation credit for the development of QR-110, the company’s Leber’s…

Perspective

What to look forward to at Retina World Congress

December 7, 2018
The second Retina World Congress will take place in Fort Lauderdale, Florida, March 21 to 24, bringing retina specialists from across the globe…

Blog

BLOG: Top five things to know about an innovative drug delivery system for DME

December 6, 2018
Standard therapy for the rising number of patients with diabetic macular edema typically consists of anti-VEGF treatments. However, a significant…

Health Canada approves Iluvien for DME

December 5, 2018
Iluvien has been approved by Health Canada, Alimera Sciences announced in a press release. A fluocinolone acetonide sustained-release intravitreal…

FDA clears IND application for ProQR’s Usher syndrome treatment

December 5, 2018
The FDA has cleared an investigational new drug application for QR-421a for Usher syndrome type 2, ProQR Therapeutics announced in a press release…

In the Journals

EyeMax Mono IOL shows promise in patients with macular disease

December 4, 2018
Visual acuity improved in patients with geographic atrophy who underwent cataract surgery and implantation of a novel monofocal IOL in the capsular…

Bausch + Lomb, Modulight to develop laser for Visudyne

December 4, 2018
Bausch + Lomb and Modulight have entered into an exclusive agreement to develop a laser for use with Visudyne photodynamic therapy, according to a…

Notal Vision’s home-based OCT system granted breakthrough device designation

December 3, 2018
The FDA has granted breakthrough device designation to Notal Vision’s home-based OCT system, according to a press release. The artificial…

IND application accepted for CRISPR genome editing treatment for LCA10

December 3, 2018
The FDA has accepted an investigational new drug application for Editas Medicine’s experimental CRISPR genome editing medicine for the…

OSN’s top news of the week

December 1, 2018
Here are five important articles from the past week you might have missed:

Top five AAO videos

November 30, 2018
At the annual American Academy of Ophthalmology meeting in Chicago, Healio.com/OSN talked with key opinion leaders regarding important ophthalmic…

In the Journals

Golimumab reduced occurrence, disease activity of acute anterior uveitis in AS

November 28, 2018
The occurrence rate and disease activity of acute anterior uveitis in ankylosing spondylitis decreased significantly during treatment with golimumab…

Europe approves first gene therapy for retinal dystrophy

November 26, 2018
On Nov. 23, the European Commission approved the first gene therapy for the treatment of inherited retinal disease related to a mutation of the…

More Headlines »